INTERNATIONAL PATENT: SHANGHAI HONGCHENG PHARMACEUTICAL CO., LTD., 上海宏成药业有限公司, CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD., 成都倍特药业股份有限公司 FILES APPLICATION FOR "ANTI-DLL3 ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF AND USE THEREOF"

Posted On: 2025-07-07

GENEVA, July 7 -- SHANGHAI HONGCHENG PHARMACEUTICAL CO., LTD. (1-2/F., BUILDING 2, NO. 500 FURONGHUA ROAD,Pudong New Area, Shanghai 201318), 上海宏成药业有限公司 (中国上海市浦东新区芙蓉花路500弄2号楼1-2层), CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. (No. 263, Hexiang 3rd Street, High-tech Zone,Chengdu, Sichuan 610094), 成都倍特药业股份有限公司 (中国四川省成都市高新区和祥三街263号) filed a patent application (PCT/CN20...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHANGHAI HONGCHENG PHARMACEUTICAL CO., LTD., 上海宏成药业有限公司, CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD., 成都倍特药业股份有限公司 FILES APPLICATION FOR "ANTI-DLL3 ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF AND USE THEREOF"